Skip to content

Chase Cardiac Analysis System

by Chase Medical, Inc.

510(k) K032531

Chase Cardiac Analysis System is a medical device (FDA Class II; FDA product code LLZ, System, Image Processing, Radiological) made by Chase Medical, Inc., cleared under FDA 510(k) K032531 on 2 Feb 2004, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK032531 Date2 Feb 2004ClearedStatusActive

Official records

From the FDA record

Received by the FDA
15 Aug 2003
FDA decision
2 Feb 2004 (Substantially Equivalent)
FDA review time
171 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K032531 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LLZ
Device class
Class II
Regulation
21 CFR Part 892.2050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Chase Medical, Inc.

See all devices from Chase Medical, Inc. →